Ricoh Sells 3D Healthcare Business to Myrava, Inc.

Ricoh USA has sold its Ricoh 3D for Healthcare business, which specialized in patient-specific medical devices, to Myrava, Inc. This move aligns with Ricoh's strategic objective to sharpen its focus on process automation, workplace experience, and business process services. The company aims to prioritize investments in scalable businesses that best fit its primary mission and strengths.

Bob Lamendola, Chief Digital Services and Delivery Officer at Ricoh USA, stated that while healthcare remains a significant growth area, patient-specific medical devices require specialized capabilities outside Ricoh's broader business priorities. This divestiture will allow the healthcare 3D printing business to scale under dedicated ownership, while Ricoh can concentrate on delivering value in areas such as cost reduction, regulatory compliance, operational efficiency, and enhancing patient and clinician experiences through its services and technology.

Myrava, Inc., led by Gary Turner (formerly Vice President and General Manager of Ricoh 3D for Healthcare), views this acquisition as a natural progression. The establishment of Ricoh 3D for Healthcare as a standalone entity last year created a focused structure for the specialized and rapidly growing market. As an independent company, Myrava, Inc. anticipates benefiting from dedicated investment and leadership focused on advancing personalized, FDA-cleared medical devices and point-of-care manufacturing for healthcare providers.

The Ricoh 3D for Healthcare business was launched in 2025, having previously operated as an internal 3D medical manufacturing center. The sale signifies Ricoh's strategic realignment towards its core competencies, enabling the specialized medical device sector to pursue independent growth and innovation.